#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Biliary cancer metastatic Malignant central nervous system neoplasm Pulmonary fibrosis Neoplasm Neuropathic arthropathy Encephalopathy neonatal Hypoparathyroidism Phaeochromocytoma Measles Metastatic malignant melanoma Myasthenia gravis Heart disease congenital Spinal cord injury Cardiac arrest Chondrosarcoma More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Alagille syndrome – Basic Information Arterial tortuosity syndrome Leiomyosarcoma metastatic Advanced systemic mastocytosis – Basic Information Angiosarcoma metastatic – Life with Disease Soft tissue sarcoma – Basic Information Mucopolysaccharidosis III – Life with Disease Idiopathic inflammatory myopathy – Trials in Disease Castleman’s disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    LIGUFALIMAB Omalizumab Tramadol Hydrochloride Magnesium Sulfate Heptahydrate AZD1163 Setmelanotide Jnj-81241459 Highly Refined Fish Oil Relebactam Ivermectin L-Histidine Hydrochloride Mitomycin Tradipitant Pemigatinib Abiraterone Acetate ALE.P03 Lactose Monohydrate Clopidogrel Methylprednisolone Aceponate Solrikitug More therapies…

    Learn about Your Condition

    Endotracheal intubation Haemoptysis Osteochondrodysplasia Cystic fibrosis lung Lennox-Gastaut syndrome HER2 negative breast cancer Adenosquamous cell lung cancer Circulatory collapse Cortical dysplasia Neonatal respiratory failure Systemic sclerosis pulmonary Mucopolysaccharidosis II Langerhans cell sarcoma Laryngeal cancer stage I Propionic acidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study of rituximab followed by cladribine for patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • ACICLOVIR SODIUM
    • Pseudoephedrine Hydrochloride
    • Cetirizine Dihydrochloride
    Sweden

  • A Study of Acoramidis for Long-Term Safety in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Acquired ATTR amyloidosis
    Investigated Drugs:
    • Acoramidis Hydrochloride
    Belgium Denmark France Germany Greece Ireland +5

  • Study of Lactobacillales and Lacidofil in Multiple Sclerosis Patients: Comparing Effectiveness of Probiotic Therapy

    Not yet recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    • Multiple sclerosis
    Investigated Drugs:
    • Lactobacillus Rhamnosus, Strain Lcr35, Live
    • Ozanimod
    • Ofatumumab
    Poland

  • Study of Probenecid for Controlling Cluster Seizures in Patients with Focal Epilepsy During Pre-surgical Video-EEG Monitoring

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Partial seizures
    France

  • Study of Tenofovir Alafenamide as Add-on Treatment to Anti-CD20 Therapy in Multiple Sclerosis Patients to Reduce Neuronal Damage

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Tenofovir Alafenamide
    Norway

  • Study of Citicoline to Prevent Cognitive Decline After Delirium in Older Adults with Hip Fracture

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    Italy
Previous Page
1 … 68 69 70 71 72 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!